See more : Vaxil Bio Ltd. (VXL.V) Income Statement Analysis – Financial Results
Complete financial analysis of Vertex, Inc. (VERX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Vertex, Inc., a leading company in the Software – Application industry within the Technology sector.
You may be interested
- Logan Ridge Finance Corporation (LRFC) Income Statement Analysis – Financial Results
- U.S. Global Investors, Inc. (GROW) Income Statement Analysis – Financial Results
- DAIWA TSUSHIN Co., Ltd (7116.T) Income Statement Analysis – Financial Results
- Endeavour Mining plc (EDV.TO) Income Statement Analysis – Financial Results
- Alexander’s, Inc. (ALX) Income Statement Analysis – Financial Results
Vertex, Inc. (VERX)
About Vertex, Inc.
Vertex, Inc. provides tax technology solutions for corporations in retail, communication, leasing, and manufacturing industries in the United States and internationally. It offers tax determination, compliance and reporting, tax data management, document management, pre-built integration, and industry-specific solutions. The company sells its software products through software license and software as a service subscriptions. It also provides implementation and training services in connection with its software license and cloud subscriptions, transaction tax returns outsourcing, and other tax-related services. Vertex, Inc. was founded in 1978 and is headquartered in King of Prussia, Pennsylvania.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 572.39M | 491.62M | 425.55M | 374.67M | 321.50M | 272.40M |
| Cost of Revenue | 223.81M | 193.13M | 161.89M | 165.39M | 110.38M | 95.70M |
| Gross Profit | 348.58M | 298.49M | 263.66M | 209.28M | 211.12M | 176.71M |
| Gross Profit Ratio | 60.90% | 60.72% | 61.96% | 55.86% | 65.67% | 64.87% |
| Research & Development | 58.21M | 41.88M | 44.02M | 54.34M | 30.56M | 23.76M |
| General & Administrative | 145.94M | 121.65M | 107.01M | 149.06M | 71.01M | 58.95M |
| Selling & Marketing | 140.24M | 125.34M | 99.01M | 99.42M | 68.13M | 56.90M |
| SG&A | 286.17M | 246.99M | 206.01M | 248.48M | 139.14M | 115.85M |
| Other Expenses | 21.70M | 17.71M | 16.57M | 11.22M | 9.57M | 7.25M |
| Operating Expenses | 366.09M | 306.57M | 266.60M | 314.04M | 179.27M | 146.85M |
| Cost & Expenses | 579.81M | 499.71M | 428.49M | 479.42M | 289.65M | 242.54M |
| Interest Income | 0.00 | 1.68M | 984.00K | 1.72M | 1.08M | 526.00K |
| Interest Expense | 4.16M | 2.05M | 984.00K | 3.11M | 2.04M | 1.59M |
| Depreciation & Amortization | 74.46M | 76.28M | 56.73M | 32.22M | 25.19M | 24.90M |
| EBITDA | 56.95M | 53.07M | 41.84M | -72.54M | 58.13M | 22.07M |
| EBITDA Ratio | 9.95% | 10.80% | 9.83% | -19.36% | 18.08% | 20.10% |
| Operating Income | -7.42M | -8.08M | -2.94M | -104.76M | 31.86M | -2.83M |
| Operating Income Ratio | -1.30% | -1.64% | -0.69% | -27.96% | 9.91% | -1.04% |
| Total Other Income/Expenses | -14.25M | -2.05M | -984.00K | -3.11M | -953.00K | -34.41M |
| Income Before Tax | -21.67M | -10.13M | -3.93M | -107.87M | 30.90M | -4.43M |
| Income Before Tax Ratio | -3.79% | -2.06% | -0.92% | -28.79% | 9.61% | -1.63% |
| Income Tax Expense | -8.58M | 2.17M | -2.45M | -28.93M | 7.83M | 1.68M |
| Net Income | -13.09M | -12.30M | -1.48M | -78.94M | 23.08M | -6.11M |
| Net Income Ratio | -2.29% | -2.50% | -0.35% | -21.07% | 7.18% | -2.24% |
| EPS | -0.09 | -0.08 | -0.01 | -0.54 | 0.21 | -29.08 |
| EPS Diluted | -0.09 | -0.08 | -0.01 | -0.54 | 0.21 | -29.08 |
| Weighted Avg Shares Out | 151.86M | 149.65M | 147.78M | 146.44M | 146.17M | 210.00K |
| Weighted Avg Shares Out (Dil) | 151.86M | 149.65M | 147.78M | 146.44M | 146.17M | 210.00K |
Vertex to Present at Upcoming Conferences
KING OF PRUSSIA, Pa., May 30, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX), a global provider of tax technology solutions, today announced that management will present at the following investor events:
Vertex: Poised For Long-Term Growth Driven By Multiple Pipeline Catalysts
Vertex Pharmaceuticals has a strong focus on cystic fibrosis, which is driving revenue growth and pipeline development. The company has outperformed Johnson & Johnson and the S&P 500 in terms of total returns. Near-term catalysts include advancements in CF treatment,...
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
Vertex has achieved significant growth in recent years, but things have slowed lately. The company has many potential catalysts that could accelerate its growth rate.
New Pain Drug Could Be Big For Vertex Stock As Shares Score Breakout
Cystic fibrosis treatment leader Vertex scored a breakout from a cup base this week, just a few weeks after an earnings beat.
Vertex to Participate in Upcoming June Investor Conferences
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in two upcoming investor conferences. Dr. Reshma Kewalramani, Chief Executive Officer and President, will present at the William Blair 44th Annual Growth Stock Conference on Tuesday, June 4, 2024 at...
Vertex Women Leading the Way: Four Honorees Named on CRN's 2024 Women of the Channel List
KING OF PRUSSIA, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions, today announced that CRN ® , a brand of The Channel Company, has named Sarah Bourne,...
Vertex, Inc. (VERX) Q1 2024 Earnings Call Transcript
Vertex, Inc. (NASDAQ:VERX ) Q1 2024 Earnings Conference Call May 8, 2024 8:30 AM ET Company Participants Joe Crivelli – Vice President-Investor Relations David DeStefano – President and Chief Executive Officer John Schwab – Chief Financial Officer Conference Call Participants...
Vertex Announces First Quarter 2024 Financial Results
KING OF PRUSSIA, Pa., May 08, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced financial results for its first quarter ended March 31, 2024.
Vertex, Inc. Announces Closing of Upsized Offering of $345 Million Convertible Senior Notes
KING OF PRUSSIA, Pa., April 26, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) (“Vertex”), a leading global provider of indirect tax solutions, today announced the closing of its private offering of $345 million aggregate principal amount of 0.750% convertible...
Vertex, Inc. Announces Pricing of Upsized $300 Million
KING OF PRUSSIA, Pa., April 23, 2024 (GLOBE NEWSWIRE) — Vertex, Inc. (NASDAQ: VERX) (“Vertex”), a leading global provider of indirect tax solutions, today announced the pricing of $300 million aggregate principal amount of 0.750% convertible senior notes due 2029...
Source: https://incomestatements.info
Category: Stock Reports